logo

Last Update

This profile was last updated on 8/12/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong David Kleinman?

David M. Kleinman

Chief of Ophthalmology

Denver Health

HQ Phone:  (303) 436-6000

Email: d***@***.org

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Denver Health

777 Bannock Street MC 0278

Denver, Colorado,80204

United States

Company Description

Denver Health was established in 1860, and has been caring for the people of Denver and the Rocky Mountain Region ever since. Denver Health is a vast source of medical knowledge, technology and resources where every hour of every day our expert, caring staff d...more

Background Information

Employment History

Chief Medical Officer

ONL Therapeutics Inc


Associate Professor of Ophthalmology (Part Time)

Flaum Eye Institute at the University of Rochester


Chief Executive Officer

Eyeon Therapeutics, Inc.


Staff Ophthalmologist

Project Orbis


Affiliations

start-up company Eyeon Therapeutics Inc.

Founder


Education

BA

Brown University


Dean's Scholar

Simon School of Business


M.B.A.


M.D.

The University of Rochester Eye Institute


M.D.

University of Rochester Eye Institute - Donald Grover


M.D. with honors

University of Colorado School of Medicine


MBA

Simon School of Business


Web References(39 Total References)


Management - ONL Therapeutics

www.onltherapeutics.com [cached]

David M. Kleinman, M.D., M.B.A., Chief Medical Officer
Dr. Kleinman is a board-certified ophthalmologist with fellowship training in vitreoretinal surgery and more than ten years experience in venture creation and ophthalmic drug and device development. He currently serves as a part-time associated professor ophthalmology at the Flaum Eye Institute at the University of Rochester, where he specializes in the medical and surgical care of patients with retinal disease. David is the former chief of ophthalmology at Denver Health Medical Center, where he also served as an assistant professor of ophthalmology at the Rocky Mountain Lions Eye Institute. In 2003, he helped found MacuSight, a venture capital backed retinal drug development company, where served as consulting medical director. In his role with MacuSight, David assisted in guiding the company through Series A financing, pre-clinical studies, initial investigational new drug (IND) submission, and Phase I/II clinical development. MacuSight's assets were acquired by Santen in 2010. He holds a bachelor's degree from Brown University, an MBA from the Simon School of Business, and an M.D. with honors from the University of Colorado School of Medicine.


Management – ONL Therapeutics

www.onltherapeutics.com [cached]

David M. Kleinman, M.D., M.B.A., Chief Medical Officer
Dr. Kleinman is a board-certified ophthalmologist with fellowship training in vitreoretinal surgery and more than ten years experience in venture creation and ophthalmic drug and device development. He currently serves as a part-time associated professor ophthalmology at the Flaum Eye Institute at the University of Rochester, where he specializes in the medical and surgical care of patients with retinal disease. David is the former chief of ophthalmology at Denver Health Medical Center, where he also served as an assistant professor of ophthalmology at the Rocky Mountain Lions Eye Institute. In 2003, he helped found MacuSight, a venture capital backed retinal drug development company, where served as consulting medical director. In his role with MacuSight, David assisted in guiding the company through Series A financing, pre-clinical studies, initial investigational new drug (IND) submission, and Phase I/II clinical development. MacuSight's assets were acquired by Santen in 2010. He holds a bachelor's degree from Brown University, an MBA from the Simon School of Business, and an M.D. with honors from the University of Colorado School of Medicine.


www.specialtypharma.com

Dr. David M. Kleinman
President, CEO & Co-Founder Eyeon Therapeutics, Inc. Dr. David M. Kleinman is President, CEO, and Co-founder of Eyeon Therapeutics, Inc., an early stage ophthalmology firm developing novel technologies to treat eye diseases. Eyeon Therapeutics and Particle Sciences, Inc. have formed a joint venture to commercialize PEGPLUSTM as an improved therapy for dry eye syndrome. Dr. Kleinman is a board-certified ophthalmologist with fellowship training in vitreoretinal surgery, and he also serves as a part-time Associate Professor of Ophthalmology at the Flaum Eye Institute at the University of Rochester. In addition to running Eyeon Therapeutics and working at the Flaum Eye Institute, he consults for biotechnology, medical device, pharmaceutical, and investment firms nationally. He has helped multiple start-ups develop intellectual property, generate preclinical data, raise money, submit regulatory filings, and complete proof-of-principle and Phase I clinical trials. He also assists larger companies with due diligence and pharmaceutical development in ophthalmology. He is the former Chief of Ophthalmology at Denver Health Medical Center in Denver. He earned his BA from Brown University, his MD with honors from the University of Colorado School of Medicine, and graduated as a Dean's Scholar from the Simon School of Business.


David Kleinman, M.D. - Flaum Eye Institute - Retina

www.stronghealth.com [cached]

David Kleinman, M.D., M.B.A.
Part-Time Assistant Professor Department of Ophthalmology David M. Kleinman, MD, MBA, FACS is a board certified ophthalmologist with fellowship training in vitreoretinal surgery. Dr. Kleinman received his medical degree with honors and completed a subsequent residency in ophthalmology at the University of Colorado School of Medicine. He then recieved additional training through a fellowship in vitreoretinal surgery at the University of Toronto School of Medicine. Dr. Kleinman is the former Chief of Ophthalmology at Denver Health Medical Center in Denver, Colorado where he also served as Director of Ophthalmic Trauma Services and Assistant Professor of Ophthalmology at the Rocky Mountain Lions Eye Institute. Besides attending to his clinical practice at the University of Rochester Eye Institute, Dr. Kleinman is President and Co-founder of Eyeon Therapeutics, Inc. a start-up firm developing new treatments for eye diseases. He also serves as a consultant to both large and small ophthalmic pharmaceutical and device companies nationally. Dr. Kleinman's research involves the pharmaceutical treatment of diabetic retinopathy and age related macular degeneration. He has made numerous contributions to clinical and research publications in national and international journals of ophthalmology, and has made presentations throughout the world. In addition, he participated as a surgeon for the Himalayan Cataract Project and served as a staff ophthalmologist for Project ORBIS International, Inc. Dr. Kleinman sees patients at our Strong Memorial Hospital offices .


David Kleinman, M.D. - University of Rochester Eye Institute - Retina

www.stronghealth.org [cached]

David Kleinman, M.D., M.B.A. David M. Kleinman, MD, MBA, FACS is a board certified ophthalmologist with fellowship training in vitreoretinal surgery.Dr. Kleinman received his medical degree with honors and completed a subsequent residency in ophthalmology at the University of Colorado School of Medicine.He then recieved additional training through a fellowship in vitreoretinal surgery at the University of Toronto School of Medicine.Dr. Kleinman is the former Chief of Ophthalmology at Denver Health Medical Center in Denver, Colorado where he also served as Director of Ophthalmic Trauma Services and Assistant Professor of Ophthalmology at the Rocky Mountain Lions Eye Institute. Besides attending to his clinical practice at the University of Rochester Eye Institute, Dr. Kleinman is President and Co-founder of Eyeon Therapeutics, Inc. a start-up firm developing new treatments for eye diseases.He also serves as a consultant to both large and small ophthalmic pharmaceutical and device companies nationally.Dr. Kleinman's research involves the pharmaceutical treatment of diabetic retinopathy and age related macular degeneration.He has made numerous contributions to clinical and research publications in national and international journals of ophthalmology, and has made presentations throughout the world.In addition, he participated as a surgeon for the Himalayan Cataract Project and served as a staff ophthalmologist for Project ORBIS International, Inc.Dr. Kleinman sees patients at our Strong Memorial Hospital offices.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory